Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brodalumab vs Fumaric Acid Esters in Moderate to Severe Plaque Psoriasis
NCT03331835Phase 4Completed
- Sponsor
- LEO Pharma
- Start
- Nov 2017
- Primary completion
- Jan 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of brodalumab in plaque psoriasis, sponsored by LEO Pharma. Started Nov 2017; status: completed.
02
Drugs
brodalumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03331835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03331835.